Impact of the Presence and Proportion of GGO on Survival and Pathological Characteristics in Clinical Stage I Lung Adenocarcinoma

被引：0
|
作者：
Katsumata, S. [1 ]
Aokage, K. [2 ]
Ishii, G. [3 ]
Nakasone, S. [1 ]
Miyoshi, T. [1 ]
Tane, K. [1 ]
Tsuboi, M. [1 ]
机构：
[1] Natl Canc Ctr Hosp East, Thorac Surg, Kashiwa, Chiba, Japan
[2] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[3] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
lung adenocarcinoma; ground-glass opacity; consolidation-to-tumor ratio;
D O I：
10.1016/j.jtho.2019.08.1141
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.13-04
引用
收藏
页码：S547 / S547
页数：1
相关论文
共 50 条
  • [21] Gene expression profiling by targeted RNA sequencing in pathological stage I lung adenocarcinoma with a solid component
    Kidokoro, Yoshiteru
    Sakabe, Tomohiko
    Haruki, Tomohiro
    Kadonaga, Taichi
    Nosaka, Kanae
    Nakamura, Hiroshige
    Umekita, Yoshihisa
    LUNG CANCER, 2020, 147 : 56 - 63
  • [22] Minor Components of Solid Pattern is a Significant Poor Prognostic Factor in Pathological Stage I Lung Adenocarcinoma
    Huang, M.
    Li, S.
    Yang, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S768 - S769
  • [23] Matrix Metallopeptidase-Gene Signature Predicts Stage I Lung Adenocarcinoma Survival Outcomes
    Liu, Chia-Hsin
    Di, Yuanpu Peter
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [24] High grade tumor budding is associated with poor survival in pathologic stage I lung adenocarcinoma
    Gurcay, Nesrin
    Acar, Leyla Nesrin
    Unal, Tuba Dilay Kokenek
    Tanrikulu, Fatma Benli
    Biner, Inci Uslu
    Bulut, Sertan
    Baykal, Husnu
    Demirag, Funda
    Findik, Gokturk
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2023, 66
  • [25] Clinical implication of minimal presence of solid or micropapillary subtype in early-stage lung adenocarcinoma
    Choi, Sun Ha
    Jeong, Ji Yun
    Lee, Shin Yup
    Shin, Kyung Min
    Jeong, Shin Young
    Park, Tae-In
    Do, Young Woo
    Lee, Eung Bae
    Seok, Yangki
    Lee, Won Kee
    Park, Ji Eun
    Park, Sunji
    Lee, Yong Hoon
    Seo, Hyewon
    Yoo, Seung Soo
    Lee, Jaehee
    Cha, Seung-Ick
    Kim, Chang Ho
    Park, Jae Yong
    THORACIC CANCER, 2021, 12 (02) : 235 - 244
  • [26] Resected stage I anaplastic lymphoma kinase-positive lung adenocarcinoma has a negative impact on recurrence-free survival
    Fujibayashi, Yusuke
    Tane, Shinya
    Kitazume, Mai
    Kuroda, Sanae
    Kimura, Kenji
    Kitamura, Yoshitaka
    Nishio, Wataru
    THORACIC CANCER, 2022, 13 (08) : 1109 - 1116
  • [27] Stage I lung adenocarcinoma: the value of quantitative CT in differentiating pathological subtypes and predicting growth of subsolid nodules
    Xu, Xianqun
    Wu, Kaisong
    Zhao, Yanyan
    Mei, Liejun
    MEDICINE, 2017, 96 (16)
  • [28] Ground Glass Opacity and Adjuvant Chemotherapy in Pathological Stage IB-IIA Lung Adenocarcinoma
    Zhai, Wenyu
    Gong, Li
    Zheng, Yuzhen
    Yan, Qihang
    Lai, Renchun
    Liang, Dachuan
    Wong, Wingshing
    Dai, Shuqin
    Wang, Junye
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [29] Long-term prognostic characteristics of patients with clinical stage IA part-solid lung adenocarcinoma: a conditional survival analysis
    Shen, Xinchen
    Zhao, Mengmeng
    Deng, Jiajun
    Chen, Tao
    Wen, Jialiang
    Xu, Long
    Huang, Shenghao
    Wu, Junqi
    Sun, Weiyan
    Ren, Longbing
    She, Yunlang
    Hou, Likun
    Chen, Chang
    Zhao, Deping
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2024, 66 (03)
  • [30] The impact of postoperative adjuvant therapy on EGFR-mutated stage IA lung adenocarcinoma with micropapillary pathological subtypes
    Cheng, Ran
    Hao, Zhexue
    Qiu, Li
    Zheng, Xiang
    Huang, Sihe
    Xian, Jianzhao
    Huang, Haoyang
    Li, Jianfu
    Zhang, Zhenhui
    Ye, Kaiwen
    Wu, Wentao
    Zhang, Yaowen
    Liu, Jun
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
12345